Literature DB >> 19956097

Remapping the type I diabetes association of the CTLA4 locus.

H-Q Qu1, J P Bradfield, S F A Grant, H Hakonarson, C Polychronakos.   

Abstract

The Type I Diabetes Genetics Consortium genotyped 24 single-nucleotide polymorphisms (SNPs) in the CTLA4 locus in 2298 type I diabetes (T1D) nuclear families (11 159 individuals, 5003 affected) to evaluate the recognized T1D association. The 24 CTLA4 SNPs span approximately 43 kb from the 5' flanking to 3' flanking region of the gene in the middle of an extended region of linkage disequilibrium of more than 100 kb. The genotyping was performed using two technologies (Illumina GoldenGate and Sequenom iPlex) on the same samples. The genotype calls by both the methods were highly consistent (the majority >99%). Previously reported T1D association from both the +49G>A and the CT60 SNPs was replicated. The reported association of the -319C>T SNP was not replicated. Although associated with T1D risk, it is likely that neither SNP is causative, as the peak of T1D association was from the SNP rs231727 at 3' flanking of the CTLA4 gene. Comprehensive resequencing and fine mapping of the CTLA4 region are still needed to clarify the causal variants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956097      PMCID: PMC2805453          DOI: 10.1038/gene.2009.88

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  24 in total

Review 1.  Adaptation of the extended transmission/disequilibrium test to distinguish disease associations of multiple loci: the Conditional Extended Transmission/Disequilibrium Test.

Authors:  B P Koeleman; F Dudbridge; H J Cordell; J A Todd
Journal:  Ann Hum Genet       Date:  2000-05       Impact factor: 1.670

Review 2.  The genetics of Graves' disease.

Authors:  S C Gough
Journal:  Endocrinol Metab Clin North Am       Date:  2000-06       Impact factor: 4.741

3.  The family based association test method: strategies for studying general genotype--phenotype associations.

Authors:  S Horvath; X Xu; N M Laird
Journal:  Eur J Hum Genet       Date:  2001-04       Impact factor: 4.246

4.  Structure of murine CTLA-4 and its role in modulating T cell responsiveness.

Authors:  D A Ostrov; W Shi; J C Schwartz; S C Almo; S G Nathenson
Journal:  Science       Date:  2000-10-27       Impact factor: 47.728

5.  Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese.

Authors:  D Osei-Hyiaman; L Hou; R Zhiyin; Z Zhiming; H Yu; A A Amankwah; S Harada
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

6.  Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease.

Authors:  M Takara; I Komiya; Y Kinjo; T Tomoyose; S Yamashiro; H Akamine; M Masuda; N Takasu
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

7.  Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children.

Authors:  Y J Lee; F Y Huang; F S Lo; W C Wang; C H Hsu; H A Kao; T Y Yang; J G Chang
Journal:  Clin Endocrinol (Oxf)       Date:  2000-02       Impact factor: 3.478

Review 8.  T-cell regulation by CD28 and CTLA-4.

Authors:  M L Alegre; K A Frauwirth; C B Thompson
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

9.  CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.

Authors:  T Kouki; Y Sawai; C A Gardine; M E Fisfalen; M L Alegre; L J DeGroot
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

10.  A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activation.

Authors:  Mathias Mäurer; Silke Loserth; Annette Kolb-Mäurer; Anke Ponath; Stefan Wiese; Niels Kruse; Peter Rieckmann
Journal:  Immunogenetics       Date:  2002-03-12       Impact factor: 2.846

View more
  23 in total

1.  Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex.

Authors:  Erin E Baschal; Suparna A Sarkar; Theresa A Boyle; Janet C Siebert; Jean M Jasinski; Katharine R Grabek; Taylor K Armstrong; Sunanda R Babu; Pamela R Fain; Andrea K Steck; Marian J Rewers; George S Eisenbarth
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

2.  Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population.

Authors:  M V Prasad Linga Reddy; H Wang; S Liu; B Bode; J C Reed; R D Steed; S W Anderson; L Steed; D Hopkins; J-X She
Journal:  Genes Immun       Date:  2011-01-27       Impact factor: 2.676

3.  Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians.

Authors:  Jihen Benmansour; Mouna Stayoussef; Fayza A Al-Jenaidi; Mansoor H Rajab; Chiheb B Rayana; Hichem B Said; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

Review 4.  Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?

Authors:  Anabelle Visperas; Dario A A Vignali
Journal:  J Immunol       Date:  2016-11-15       Impact factor: 5.422

Review 5.  T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Authors:  Eoin F McKinney; Kenneth Gc Smith
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

6.  Overview of the Type I Diabetes Genetics Consortium.

Authors:  S S Rich; B Akolkar; P Concannon; H Erlich; J E Hilner; C Julier; G Morahan; J Nerup; C Nierras; F Pociot; J A Todd
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

7.  The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.

Authors:  C Julier; B Akolkar; P Concannon; G Morahan; C Nierras; A Pugliese
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

Review 8.  Tim-3, Lag-3, and TIGIT.

Authors:  Nicole Joller; Vijay K Kuchroo
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 9.  Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

Authors:  Ana C Anderson; Nicole Joller; Vijay K Kuchroo
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.